| 0 |
DEATH |
70 |
| 1 |
OFF LABEL USE |
29 |
| 2 |
DRUG INEFFECTIVE |
25 |
| 3 |
NAUSEA |
25 |
| 4 |
FEBRILE NEUTROPENIA |
22 |
| 5 |
NEUTROPENIA |
22 |
| 6 |
PRODUCT QUALITY ISSUE |
21 |
| 7 |
DIARRHOEA |
18 |
| 8 |
HOSPITALISATION |
18 |
| 9 |
VOMITING |
18 |
| 10 |
DEVICE LEAKAGE |
17 |
| 11 |
PYREXIA |
17 |
| 12 |
NEEDLE ISSUE |
15 |
| 13 |
FATIGUE |
13 |
| 14 |
PRODUCT DOSE OMISSION ISSUE |
13 |
| 15 |
BONE PAIN |
11 |
| 16 |
DEVICE ISSUE |
11 |
| 17 |
PNEUMONIA |
11 |
| 18 |
RASH |
11 |
| 19 |
DISEASE PROGRESSION |
10 |
| 20 |
ASTHENIA |
9 |
| 21 |
DEVICE DEFECTIVE |
9 |
| 22 |
MYALGIA |
9 |
| 23 |
PAIN |
9 |
| 24 |
SEPSIS |
9 |
| 25 |
DEVICE BREAKAGE |
8 |
| 26 |
DEVICE MECHANICAL ISSUE |
8 |
| 27 |
PRODUCT STORAGE ERROR |
8 |
| 28 |
DECREASED APPETITE |
7 |
| 29 |
ILLNESS |
7 |
| 30 |
MALIGNANT NEOPLASM PROGRESSION |
7 |
| 31 |
WHITE BLOOD CELL COUNT DECREASED |
7 |
| 32 |
ABDOMINAL PAIN UPPER |
6 |
| 33 |
DEHYDRATION |
6 |
| 34 |
DEVICE DELIVERY SYSTEM ISSUE |
6 |
| 35 |
DEVICE MALFUNCTION |
6 |
| 36 |
DYSPNOEA |
6 |
| 37 |
GASTROINTESTINAL DISORDER |
6 |
| 38 |
NASOPHARYNGITIS |
6 |
| 39 |
PAIN IN EXTREMITY |
6 |
| 40 |
PERIPHERAL SWELLING |
6 |
| 41 |
PRODUCT USE IN UNAPPROVED INDICATION |
6 |
| 42 |
SYRINGE ISSUE |
6 |
| 43 |
CHILLS |
5 |
| 44 |
CONFUSIONAL STATE |
5 |
| 45 |
DRUG HYPERSENSITIVITY |
5 |
| 46 |
HEADACHE |
5 |
| 47 |
NEOPLASM MALIGNANT |
5 |
| 48 |
NEUTROPHIL COUNT DECREASED |
5 |
| 49 |
PLATELET COUNT DECREASED |
5 |
| 50 |
ABDOMINAL DISCOMFORT |
4 |
| 51 |
ABDOMINAL PAIN |
4 |
| 52 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
4 |
| 53 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
4 |
| 54 |
CELLULITIS |
4 |
| 55 |
CONSTIPATION |
4 |
| 56 |
DYSPHAGIA |
4 |
| 57 |
EATING DISORDER |
4 |
| 58 |
GLUCOCORTICOID DEFICIENCY |
4 |
| 59 |
HYPERSENSITIVITY |
4 |
| 60 |
INCORRECT DOSE ADMINISTERED |
4 |
| 61 |
INFECTION |
4 |
| 62 |
LIPASE INCREASED |
4 |
| 63 |
MALAISE |
4 |
| 64 |
NEUROPATHY PERIPHERAL |
4 |
| 65 |
PALPITATIONS |
4 |
| 66 |
PLEURAL EFFUSION |
4 |
| 67 |
SEIZURE |
4 |
| 68 |
THERAPY CESSATION |
4 |
| 69 |
ADVERSE DRUG REACTION |
3 |
| 70 |
AGGRESSION |
3 |
| 71 |
ALOPECIA |
3 |
| 72 |
ANAEMIA |
3 |
| 73 |
ANAPHYLACTIC REACTION |
3 |
| 74 |
BACK PAIN |
3 |
| 75 |
COUGH |
3 |
| 76 |
DEEP VEIN THROMBOSIS |
3 |
| 77 |
DEPRESSION |
3 |
| 78 |
DEVICE RELATED INFECTION |
3 |
| 79 |
EMERGENCY CARE |
3 |
| 80 |
ERYTHEMA |
3 |
| 81 |
FLUSHING |
3 |
| 82 |
FULL BLOOD COUNT DECREASED |
3 |
| 83 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
| 84 |
HAEMOGLOBIN DECREASED |
3 |
| 85 |
HENOCH-SCHONLEIN PURPURA |
3 |
| 86 |
IMMUNE-MEDIATED HYPOTHYROIDISM |
3 |
| 87 |
IMMUNODEFICIENCY |
3 |
| 88 |
MUSCULAR WEAKNESS |
3 |
| 89 |
MYOCARDIAL INFARCTION |
3 |
| 90 |
OESOPHAGITIS |
3 |
| 91 |
PRODUCT DISTRIBUTION ISSUE |
3 |
| 92 |
PRODUCT DOSE OMISSION IN ERROR |
3 |
| 93 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
3 |
| 94 |
RASH GENERALISED |
3 |
| 95 |
RESPIRATORY FAILURE |
3 |
| 96 |
SEPTIC SHOCK |
3 |
| 97 |
WEIGHT DECREASED |
3 |
| 98 |
WHITE BLOOD CELL COUNT INCREASED |
3 |
| 99 |
ADVERSE EVENT |
2 |
| 100 |
AGRANULOCYTOSIS |
2 |
| 101 |
ANAPHYLACTOID REACTION |
2 |
| 102 |
ARTHRALGIA |
2 |
| 103 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
2 |
| 104 |
BLOOD PRESSURE INCREASED |
2 |
| 105 |
BODY TEMPERATURE INCREASED |
2 |
| 106 |
BONE MARROW MYELOGRAM ABNORMAL |
2 |
| 107 |
BREAST CANCER METASTATIC |
2 |
| 108 |
CARDIAC ARREST |
2 |
| 109 |
CARDIO-RESPIRATORY ARREST |
2 |
| 110 |
CHOLANGIOCARCINOMA |
2 |
| 111 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
| 112 |
COLON CANCER |
2 |
| 113 |
CORONARY ANGIOPLASTY |
2 |
| 114 |
CORONARY ARTERY OCCLUSION |
2 |
| 115 |
COVID-19 |
2 |
| 116 |
CYTOKINE RELEASE SYNDROME |
2 |
| 117 |
CYTOPENIA |
2 |
| 118 |
DELIRIUM |
2 |
| 119 |
DEVICE FAILURE |
2 |
| 120 |
DEVICE PHYSICAL PROPERTY ISSUE |
2 |
| 121 |
DEVICE USE CONFUSION |
2 |
| 122 |
DIZZINESS |
2 |
| 123 |
DYSPEPSIA |
2 |
| 124 |
DYSSTASIA |
2 |
| 125 |
ERYSIPELAS |
2 |
| 126 |
FACIAL PAIN |
2 |
| 127 |
FLUID RETENTION |
2 |
| 128 |
GENERALISED OEDEMA |
2 |
| 129 |
HAEMOPTYSIS |
2 |
| 130 |
HOSPICE CARE |
2 |
| 131 |
HYPERTENSION |
2 |
| 132 |
HYPOXIA |
2 |
| 133 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
2 |
| 134 |
IMMUNE-MEDIATED HYPERTHYROIDISM |
2 |
| 135 |
INFLUENZA |
2 |
| 136 |
INJECTION RELATED REACTION |
2 |
| 137 |
INSURANCE ISSUE |
2 |
| 138 |
INVASIVE DUCTAL BREAST CARCINOMA |
2 |
| 139 |
LEUKOPENIA |
2 |
| 140 |
MIGRAINE |
2 |
| 141 |
MUCOSAL INFLAMMATION |
2 |
| 142 |
MUSCLE SPASMS |
2 |
| 143 |
NEOPLASM |
2 |
| 144 |
NO ADVERSE EVENT |
2 |
| 145 |
NOROVIRUS INFECTION |
2 |
| 146 |
OESOPHAGEAL CANDIDIASIS |
2 |
| 147 |
PANCYTOPENIA |
2 |
| 148 |
PRODUCT DOSE OMISSION |
2 |
| 149 |
PRODUCT PACKAGING ISSUE |
2 |
| 150 |
PRODUCT PRESCRIBING ISSUE |
2 |
| 151 |
PRODUCT USE ISSUE |
2 |
| 152 |
PRODUCTIVE COUGH |
2 |
| 153 |
SMALL INTESTINE ADENOCARCINOMA |
2 |
| 154 |
TACHYCARDIA |
2 |
| 155 |
THERAPY INTERRUPTED |
2 |
| 156 |
THROMBOCYTOPENIA |
2 |
| 157 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
| 158 |
URINARY TRACT INFECTION |
2 |
| 159 |
VENOOCCLUSIVE LIVER DISEASE |
2 |
| 160 |
ABDOMINAL DISTENSION |
1 |
| 161 |
ABDOMINAL PAIN LOWER |
1 |
| 162 |
ABNORMAL FAECES |
1 |
| 163 |
ABSCESS |
1 |
| 164 |
ACCIDENT |
1 |
| 165 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
| 166 |
ACNE |
1 |
| 167 |
ACUTE KIDNEY INJURY |
1 |
| 168 |
ADVERSE REACTION |
1 |
| 169 |
ANAL FISTULA |
1 |
| 170 |
ANAPHYLACTIC SHOCK |
1 |
| 171 |
ANXIETY |
1 |
| 172 |
APLASIA |
1 |
| 173 |
APPETITE DISORDER |
1 |
| 174 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
| 175 |
ATROPHY |
1 |
| 176 |
ATYPICAL PNEUMONIA |
1 |
| 177 |
B-CELL LYMPHOMA |
1 |
| 178 |
BACTERAEMIA |
1 |
| 179 |
BENIGN NEOPLASM OF SPINAL CORD |
1 |
| 180 |
BILIARY OBSTRUCTION |
1 |
| 181 |
BLOOD BILIRUBIN INCREASED |
1 |
| 182 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
| 183 |
BLOOD GLUCOSE DECREASED |
1 |
| 184 |
BLOOD GLUCOSE INCREASED |
1 |
| 185 |
BLOOD PRESSURE ABNORMAL |
1 |
| 186 |
BLOOD TEST ABNORMAL |
1 |
| 187 |
BONE MARROW DISORDER |
1 |
| 188 |
BRAIN INJURY |
1 |
| 189 |
BREAST CANCER |
1 |
| 190 |
CANDIDA INFECTION |
1 |
| 191 |
CARDIAC DISORDER |
1 |
| 192 |
CEREBROVASCULAR ACCIDENT |
1 |
| 193 |
CHAPPED LIPS |
1 |
| 194 |
CHEST DISCOMFORT |
1 |
| 195 |
COLITIS |
1 |
| 196 |
COLON CANCER STAGE I |
1 |
| 197 |
CONDITION AGGRAVATED |
1 |
| 198 |
CONTUSION |
1 |
| 199 |
DEAFNESS |
1 |
| 200 |
DEVICE DEPLOYMENT ISSUE |
1 |
| 201 |
DEVICE DIFFICULT TO USE |
1 |
| 202 |
DEVICE DISLOCATION |
1 |
| 203 |
DEVICE OCCLUSION |
1 |
| 204 |
DEVICE SAFETY FEATURE ISSUE |
1 |
| 205 |
DIABETES MELLITUS |
1 |
| 206 |
DISABILITY |
1 |
| 207 |
DISORIENTATION |
1 |
| 208 |
DRUG INTERACTION |
1 |
| 209 |
DRUG INTOLERANCE |
1 |
| 210 |
DYSARTHRIA |
1 |
| 211 |
DYSPHONIA |
1 |
| 212 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
| 213 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
| 214 |
ENTEROCOCCAL INFECTION |
1 |
| 215 |
ENTEROCOCCAL SEPSIS |
1 |
| 216 |
EXTRA DOSE ADMINISTERED |
1 |
| 217 |
FACIAL PARALYSIS |
1 |
| 218 |
FALL |
1 |
| 219 |
FEAR |
1 |
| 220 |
FEAR OF INJECTION |
1 |
| 221 |
FEEDING DISORDER |
1 |
| 222 |
FEELING ABNORMAL |
1 |
| 223 |
FEELING COLD |
1 |
| 224 |
FEELING HOT |
1 |
| 225 |
FISTULA |
1 |
| 226 |
FLUID INTAKE REDUCED |
1 |
| 227 |
FOOD INTOLERANCE |
1 |
| 228 |
FULL BLOOD COUNT ABNORMAL |
1 |
| 229 |
GAIT INABILITY |
1 |
| 230 |
GALLBLADDER ENLARGEMENT |
1 |
| 231 |
GASTRIC CANCER RECURRENT |
1 |
| 232 |
GASTRIC DISORDER |
1 |
| 233 |
GASTRITIS |
1 |
| 234 |
GASTROINTESTINAL TUBE INSERTION |
1 |
| 235 |
GRAFT VERSUS HOST DISEASE |
1 |
| 236 |
HAEMATURIA |
1 |
| 237 |
HAEMORRHAGE |
1 |
| 238 |
HAEMORRHAGE URINARY TRACT |
1 |
| 239 |
HAEMORRHAGIC STROKE |
1 |
| 240 |
HEPATIC ENZYME INCREASED |
1 |
| 241 |
HODGKIN^S DISEASE REFRACTORY |
1 |
| 242 |
HOT FLUSH |
1 |
| 243 |
HYDROCELE |
1 |
| 244 |
HYPERAESTHESIA |
1 |
| 245 |
HYPOALBUMINAEMIA |
1 |
| 246 |
HYPOKALAEMIA |
1 |
| 247 |
HYPONATRAEMIA |
1 |
| 248 |
HYPOTENSION |
1 |
| 249 |
HYPOTHYROIDISM |
1 |
| 250 |
IMMUNE SYSTEM DISORDER |
1 |
| 251 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
| 252 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
| 253 |
INFLAMMATION |
1 |
| 254 |
INJECTION SITE BRUISING |
1 |
| 255 |
INJECTION SITE DISCHARGE |
1 |
| 256 |
INJECTION SITE ERYTHEMA |
1 |
| 257 |
INJURY ASSOCIATED WITH DEVICE |
1 |
| 258 |
INTENTIONAL DOSE OMISSION |
1 |
| 259 |
INTENTIONAL PRODUCT MISUSE |
1 |
| 260 |
INTESTINAL SEPSIS |
1 |
| 261 |
KIDNEY INFECTION |
1 |
| 262 |
KLEBSIELLA INFECTION |
1 |
| 263 |
LABORATORY TEST ABNORMAL |
1 |
| 264 |
LACRIMATION INCREASED |
1 |
| 265 |
LETHARGY |
1 |
| 266 |
LEUKOCYTOSIS |
1 |
| 267 |
LIMB INJURY |
1 |
| 268 |
LIP DRY |
1 |
| 269 |
LIVER DISORDER |
1 |
| 270 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
| 271 |
LYMPHADENOPATHY |
1 |
| 272 |
MASS |
1 |
| 273 |
MEMORY IMPAIRMENT |
1 |
| 274 |
MOUTH ULCERATION |
1 |
| 275 |
MUCOUS STOOLS |
1 |
| 276 |
MUSCLE TIGHTNESS |
1 |
| 277 |
MYELODYSPLASTIC SYNDROME |
1 |
| 278 |
MYELOID LEUKAEMIA |
1 |
| 279 |
MYELOSUPPRESSION |
1 |
| 280 |
MYOSITIS |
1 |
| 281 |
NECK PAIN |
1 |
| 282 |
NECROSIS |
1 |
| 283 |
NEOPLASM PROGRESSION |
1 |
| 284 |
NEPHROLITHIASIS |
1 |
| 285 |
NEUROENDOCRINE TUMOUR OF THE RECTUM |
1 |
| 286 |
NEUTROPENIC COLITIS |
1 |
| 287 |
NEUTROPHIL COUNT ABNORMAL |
1 |
| 288 |
OCULAR HYPERAEMIA |
1 |
| 289 |
OEDEMA PERIPHERAL |
1 |
| 290 |
ONYCHOMADESIS |
1 |
| 291 |
ORAL PAIN |
1 |
| 292 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
| 293 |
PANCREATITIS |
1 |
| 294 |
PANNICULITIS |
1 |
| 295 |
PHOTOPHOBIA |
1 |
| 296 |
PLASMA CELL MYELOMA IN REMISSION |
1 |
| 297 |
PLASMA CELLS INCREASED |
1 |
| 298 |
PLATELET COUNT ABNORMAL |
1 |
| 299 |
PNEUMOCYSTIS JIROVECII INFECTION |
1 |
| 300 |
PNEUMONIA ASPIRATION |
1 |
| 301 |
PNEUMOTHORAX |
1 |
| 302 |
PO2 DECREASED |
1 |
| 303 |
POLLAKIURIA |
1 |
| 304 |
PRESCRIBED UNDERDOSE |
1 |
| 305 |
PRODUCT COMMUNICATION ISSUE |
1 |
| 306 |
PRODUCT LABEL CONFUSION |
1 |
| 307 |
PRODUCT ORIGIN UNKNOWN |
1 |
| 308 |
PRODUCT PACKAGING QUANTITY ISSUE |
1 |
| 309 |
PROSTATE CANCER |
1 |
| 310 |
PULMONARY MASS |
1 |
| 311 |
RASH ERYTHEMATOUS |
1 |
| 312 |
RASH PAPULAR |
1 |
| 313 |
RASH VESICULAR |
1 |
| 314 |
RED BLOOD CELL COUNT DECREASED |
1 |
| 315 |
RENAL FAILURE |
1 |
| 316 |
RENAL IMPAIRMENT |
1 |
| 317 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
| 318 |
RESPIRATORY TRACT INFECTION |
1 |
| 319 |
RHABDOMYOLYSIS |
1 |
| 320 |
RHINITIS ALLERGIC |
1 |
| 321 |
RHINORRHOEA |
1 |
| 322 |
SARCOMA |
1 |
| 323 |
SECOND PRIMARY MALIGNANCY |
1 |
| 324 |
SEPTIC EMBOLUS |
1 |
| 325 |
SINUS TACHYCARDIA |
1 |
| 326 |
SINUSITIS |
1 |
| 327 |
SKIN ABRASION |
1 |
| 328 |
SKIN PAPILLOMA |
1 |
| 329 |
SPINAL CORD COMPRESSION |
1 |
| 330 |
SPINAL CORD INJURY |
1 |
| 331 |
SPLENIC INFARCTION |
1 |
| 332 |
SPLENIC RUPTURE |
1 |
| 333 |
STAPHYLOCOCCAL SEPSIS |
1 |
| 334 |
STRESS |
1 |
| 335 |
SURGERY |
1 |
| 336 |
SUSPECTED OFF LABEL USE |
1 |
| 337 |
SWELLING |
1 |
| 338 |
SYNCOPE |
1 |
| 339 |
TACHYPNOEA |
1 |
| 340 |
TENDERNESS |
1 |
| 341 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
| 342 |
THROMBOSIS |
1 |
| 343 |
THYROID DISORDER |
1 |
| 344 |
TONGUE PARALYSIS |
1 |
| 345 |
TOXIC SKIN ERUPTION |
1 |
| 346 |
TRANSFUSION |
1 |
| 347 |
TREMOR |
1 |
| 348 |
TRISMUS |
1 |
| 349 |
UNEVALUABLE EVENT |
1 |
| 350 |
UNRESPONSIVE TO STIMULI |
1 |
| 351 |
URINARY INCONTINENCE |
1 |
| 352 |
URINARY RETENTION |
1 |
| 353 |
URINARY TRACT OBSTRUCTION |
1 |
| 354 |
URTICARIA |
1 |
| 355 |
VASCULITIS |
1 |
| 356 |
VIRAL INFECTION |
1 |
| 357 |
VIRAL SKIN INFECTION |
1 |
| 358 |
VISUAL IMPAIRMENT |
1 |
| 359 |
VITAMIN D DEFICIENCY |
1 |
| 360 |
WHITE BLOOD CELL COUNT ABNORMAL |
1 |
| 361 |
WHITE BLOOD CELL DISORDER |
1 |
| 362 |
WOUND |
1 |
| 363 |
WRONG SCHEDULE |
1 |
| 364 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
| 365 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |